Gut microbiota-derived butyrate mediates the anticolitic effect of indigo supplementation through regulating CD4⁺ T cell differentiation

References

[1] Wangchuk, Phurpa, Karma Yeshi, and Alex Loukas. 2024. “Ulcerative Colitis: Clinical Biomarkers, Therapeutic Targets, and Emerging Treatments.” Trends in Pharmacological Sciences 45: 892-903. https://doi.org/10.1016/j.tips.2024.08.003

[2] D'Amico, Ferdinando, Laurent Peyrin-Biroulet, and Silvio Danese. 2023. “Disease Clearance in Ulcerative Colitis: Is the Ultimate Therapeutic Target?” United European Gastroenterology Journal 11: 717-719. https://doi.org/10.1002/ueg2.12436

[3] Feuerstein, Joseph D., Alan C. Moss, and Francis A. Farraye. 2019. “Ulcerative Colitis.” Mayo Clinic Proceedings 94: 1357-1373. https://doi.org/10.1016/j.mayocp.2019.01.018

[4] Weingarden, Alexa R., and Byron P. Vaughn. 2017. “Intestinal Microbiota, Fecal Microbiota Transplantation, and Inflammatory Bowel Disease.” Gut Microbes 8: 238-252. https://doi.org/10.1080/19490976.2017.1290757

[5] Zmora, Niv, Jotham Suez, and Eran Elinav. 2019. “You Are What You Eat: Diet, Health and the Gut Microbiota.” Nature Reviews Gastroenterology & Hepatology 16: 35-56. https://doi.org/10.1038/s41575-018-0061-2

[6] Xing, Changsheng, Mingjun Wang, Adebusola A. Ajibade, Peng Tan, Chuntang Fu, Lang Chen, Motao Zhu, et al 2021. “Microbiota Regulate Innate Immune Signaling and Protective Immunity Against Cancer.” Cell Host & Microbe 29: 959-974. https://doi.org/10.1016/j.chom.2021.03.016

[7] Ivanov, Ivaylo I., Timur Tuganbaev, Ashwin N. Skelly, and Kenya Honda. 2022. “T Cell Responses to the Microbiota.” Annual Review of Immunology 40: 559-587. https://doi.org/10.1146/annurev-immunol-101320-011829

[8] Yan, Junbin, Minmin Luo, Zhiyun Chen, and Beihui He. 2020. “The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease.” Journal of Immunology Research 2020: 8813558. https://doi.org/10.1155/2020/8813558

[9] Cheng, Hongyu, Xiong Guan, Dekun Chen, and Wentao Ma. 2019. “The Th17/Treg Cell Balance: A Gut Microbiota-Modulated Story.” Microorganisms 7: 583. https://doi.org/10.3390/microorganisms7120583

[10] Sun, Chaoyue, Na Yang, Zuoliang Zheng, Dong Liu, and Qilin Xu. 2023. “T Helper 17 (Th17) Cell Responses to the Gut Microbiota in Human Diseases.” Biomedecine & Pharmacotherapie 161: 114483. https://doi.org/10.1016/j.biopha.2023.114483

[11] Shen, Zhaohua, Weiwei Luo, Bei Tan, Kai Nie, Minzi Deng, Shuai Wu, Mengwei Xiao, et al. 2022. “Roseburia Intestinalis Stimulates TLR5-Dependent Intestinal Immunity Against Crohn's Disease.” EBioMedicine 85: 104285. https://doi.org/10.1016/j.ebiom.2022.104285

[12] Ruan, Guangcong, Minjia Chen, Lu Chen, Fenghua Xu, Zhifeng Xiao, Ailin Yi, Yuting Tian, et al. 2022. “Roseburia Intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 Through the SP3 Signaling Pathway.” Nutrients 14: 3041. https://doi.org/10.3390/nu14153041

[13] Szwed, Angelia, Eugene Kim, and Estela Jacinto. 2021. “Regulation and Metabolic Functions of mTORC1 and mTORC2.” Physiological Reviews 101: 1371-1426. https://doi.org/10.1152/physrev.00026.2020

[14] Linke, Monika, Stephanie Deborah Fritsch, Nyamdelger Sukhbaatar, Markus Hengstschläger, and Thomas Weichhart. 2017. “mTORC1 and mTORC2 as Regulators of Cell Metabolism in Immunity.” FEBS Letters 591: 3089-3103. https://doi.org/10.1002/1873-3468.12711

[15] Dang, Eric V., Joseph Barbi, Huang-Yu Yang, Dilini Jinasena, Hong Yu, Ying Zheng, Zachary Bordman, et al. 2011. “Control of T(H)17/T(reg) Balance by Hypoxia-Inducible Factor 1.” Cell 146: 772-784. https://doi.org/10.1016/j.cell.2011.07.033

RIGHTS & PERMISSIONS

2025 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.